We are analyzing https://link.springer.com/article/10.1186/1472-6963-12-20.

Title:
Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians | BMC Health Services Research
Description:
Background Global coronary heart disease (CHD) risk assessment is recommended to guide primary preventive pharmacotherapy. However, little is known about physicians
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Insurance
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

risk, chd, global, physicians, assessment, patients, disease, heart, practice, primary, coronary, tools, prevention, article, adults, calculation, time, pubmed, family, general, care, guide, calculate, respondents, table, google, scholar, patient, preventive, cardiologists, survey, study, clinical, internists, reported, medicine, awareness, north, carolina, chapel, hill, sample, aware, health, compared, therapy, recommendations, years, university, office,

Topics {✒️}

multiple-risk-factor assessment equations open access article pre-publication history guideline concordant lipid-lowering coronary heart disease article download pdf web-based computer program general internist respondents recommend risk-reducing therapies prevent heart disease large multi-specialty group preventive health services risk assessment charts human research ethics privacy choices/manage cookies american heart association sheridan sl global risk assessment office-based patient care lipid lowering therapy office-based care time computer based programs global public health change physician behavior chd risk assessment risk factors change guide preventive therapy global chd risk full framingham equations cardiovascular disease prevention global risk calculation chd risk assessments full size table display risk values health sciences library calculate chd risk consensus panel guide patient risk factors chd risk calculation chd risk estimates chd risk estimation preventive care delivered high blood cholesterol chd risk calculations improves patient care mayo-smith mf comprehensive risk reduction heart disease web-based format passive guideline dissemination

Questions {❓}

, Palm device, iPhone) when seeing patients in the office?
When considering primary prevention of coronary heart disease in adults, how often do you obtain a calculation of a patient's global (overall) coronary heart disease risk?
How often do you tell the patient his/her global (overall) coronary heart disease risk estimate?
Thinking about all the patients you are considering for primary prevention of coronary heart disease, how often do you use a global (overall) coronary heart disease risk estimate to guide your recommendations about aspirin therapy?
Thinking about all the patients you are considering for primary prevention of coronary heart disease, how often do you use a global (overall) coronary heart disease risk estimate to guide your recommendations about blood pressure lowering therapy?
Thinking about all the patients you are considering for primary prevention of coronary heart disease, how often do you use a global (overall) coronary heart disease risk estimate to guide your recommendations about lipid lowering therapy?
Which one of the following do you most commonly use to obtain a patient's global (overall) coronary heart disease risk estimate?
Approximately what percent of your work time is spent in office-based patient care?
Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al: Why don't physicians follow clinical practice guidelines?
Do the computers in the exam rooms have internet access?
Do you see patients in the office or other ambulatory care setting?
Does your office practice use an electronic medical record?
Grover SA, Lowensteyn I, Esrey KL, Steinert Y, Joseph L, Abrahamowicz M: Do doctors accurately assess coronary risk in their patients?
Have you heard about tools to calculate a patient's overall risk of having a coronary heart disease event in the next 10 years (global CHD risk)?
In terms of 10-year coronary heart disease (CHD) risk, at what level of risk do you consider a patient to be "high risk" for CHD events?
In terms of 10-year coronary heart disease (CHD) risk, below what level of risk do you consider a patient to be "low risk" for CHD events?
In what year did you graduate from medical school?
In which region of the country do you practice?
In your office practice, do you use computers in the exam rooms?
Of all physicians (N = 951) who responded to the question, "Have you heard about tools to calculate a patients overall risk of coronary heart disease in the next 10 years (global CHD risk)?
Physicians who indicated that they were aware of and, "occasionally", "most of the time", or "always" obtain a calculation of a patients global CHD risk for primary prevention (based on the question, "When considering primary prevention of coronary heart disease in adults, how often do you obtain a calculation of a patient's global (overall) coronary heart disease risk?
Sheridan SL, Crespo E: Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms?
When those in this group were asked, "When considering primary prevention of CHD in adults, how often do you obtain a calculation of a patient's global (overall) coronary heart disease risk?
Which of the following best describes your office practice setting?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians
         description:Global coronary heart disease (CHD) risk assessment is recommended to guide primary preventive pharmacotherapy. However, little is known about physicians' understanding and use of global CHD risk assessment. Our objective was to examine US physicians' awareness, use, and attitudes regarding global CHD risk assessment in clinical practice, and how these vary by provider specialty. Using a web-based survey of US family physicians, general internists, and cardiologists, we examined awareness of tools available to calculate CHD risk, method and use of CHD risk assessment, attitudes towards CHD risk assessment, and frequency of using CHD risk assessment to guide recommendations of aspirin, lipid-lowering and blood pressure (BP) lowering therapies for primary prevention. Characteristics of physicians indicating they use CHD risk assessments were compared in unadjusted and adjusted analyses. A total of 952 physicians completed the questionnaire, with 92% reporting awareness of tools available to calculate CHD global risk. Among those aware of such tools, over 80% agreed that CHD risk calculation is useful, improves patient care, and leads to better decisions about recommending preventive therapies. However, only 41% use CHD risk assessment in practice. The most commonly reported barrier to CHD risk assessment is that it is too time consuming. Among respondents who calculate global CHD risk, 69% indicated they use it to guide lipid lowering therapy recommendations; 54% use it to guide aspirin therapy recommendations; and 48% use it to guide BP lowering therapy. Only 40% of respondents who use global CHD risk routinely tell patients their risk. Use of a personal digital assistant or smart phone was associated with reported use of CHD risk assessment (adjusted OR 1.58; 95% CI 1.17-2.12). Reported awareness of tools to calculate global CHD risk appears high, but the majority of physicians in this sample do not use CHD risk assessments in practice. A minority of physicians in this sample use global CHD risk to guide prescription decisions or to motivate patients. Educational interventions and system improvements to improve physicians' effective use of global CHD risk assessment should be developed and tested.
         datePublished:2012-01-24T00:00:00Z
         dateModified:2012-01-24T00:00:00Z
         pageStart:1
         pageEnd:11
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1472-6963-12-20
         keywords:
            Coronary Heart Disease
            Primary Prevention
            Family Physician
            General Internist
            Coronary Heart Disease Risk
            Public Health
            Health Administration
            Health Informatics
            Nursing Research
         image:
         isPartOf:
            name:BMC Health Services Research
            issn:
               1472-6963
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Benjamin Shillinglaw
               affiliation:
                     name:Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health
                     address:
                        name:Department of Medicine, University of Colorado Denver School of Medicine, Denver, Colorado, USA. At the time of writing, Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anthony J Viera
               affiliation:
                     name:University of North Carolina at Chapel Hill School of Medicine
                     address:
                        name:Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Teresa Edwards
               affiliation:
                     name:University of North Carolina at Chapel Hill
                     address:
                        name:Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ross Simpson
               affiliation:
                     name:University of North Carolina at Chapel Hill School of Medicine
                     address:
                        name:Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stacey L Sheridan
               affiliation:
                     name:University of North Carolina at Chapel Hill School of Medicine
                     address:
                        name:Department of Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians
      description:Global coronary heart disease (CHD) risk assessment is recommended to guide primary preventive pharmacotherapy. However, little is known about physicians' understanding and use of global CHD risk assessment. Our objective was to examine US physicians' awareness, use, and attitudes regarding global CHD risk assessment in clinical practice, and how these vary by provider specialty. Using a web-based survey of US family physicians, general internists, and cardiologists, we examined awareness of tools available to calculate CHD risk, method and use of CHD risk assessment, attitudes towards CHD risk assessment, and frequency of using CHD risk assessment to guide recommendations of aspirin, lipid-lowering and blood pressure (BP) lowering therapies for primary prevention. Characteristics of physicians indicating they use CHD risk assessments were compared in unadjusted and adjusted analyses. A total of 952 physicians completed the questionnaire, with 92% reporting awareness of tools available to calculate CHD global risk. Among those aware of such tools, over 80% agreed that CHD risk calculation is useful, improves patient care, and leads to better decisions about recommending preventive therapies. However, only 41% use CHD risk assessment in practice. The most commonly reported barrier to CHD risk assessment is that it is too time consuming. Among respondents who calculate global CHD risk, 69% indicated they use it to guide lipid lowering therapy recommendations; 54% use it to guide aspirin therapy recommendations; and 48% use it to guide BP lowering therapy. Only 40% of respondents who use global CHD risk routinely tell patients their risk. Use of a personal digital assistant or smart phone was associated with reported use of CHD risk assessment (adjusted OR 1.58; 95% CI 1.17-2.12). Reported awareness of tools to calculate global CHD risk appears high, but the majority of physicians in this sample do not use CHD risk assessments in practice. A minority of physicians in this sample use global CHD risk to guide prescription decisions or to motivate patients. Educational interventions and system improvements to improve physicians' effective use of global CHD risk assessment should be developed and tested.
      datePublished:2012-01-24T00:00:00Z
      dateModified:2012-01-24T00:00:00Z
      pageStart:1
      pageEnd:11
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1472-6963-12-20
      keywords:
         Coronary Heart Disease
         Primary Prevention
         Family Physician
         General Internist
         Coronary Heart Disease Risk
         Public Health
         Health Administration
         Health Informatics
         Nursing Research
      image:
      isPartOf:
         name:BMC Health Services Research
         issn:
            1472-6963
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Benjamin Shillinglaw
            affiliation:
                  name:Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health
                  address:
                     name:Department of Medicine, University of Colorado Denver School of Medicine, Denver, Colorado, USA. At the time of writing, Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anthony J Viera
            affiliation:
                  name:University of North Carolina at Chapel Hill School of Medicine
                  address:
                     name:Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Teresa Edwards
            affiliation:
                  name:University of North Carolina at Chapel Hill
                  address:
                     name:Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ross Simpson
            affiliation:
                  name:University of North Carolina at Chapel Hill School of Medicine
                  address:
                     name:Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stacey L Sheridan
            affiliation:
                  name:University of North Carolina at Chapel Hill School of Medicine
                  address:
                     name:Department of Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Health Services Research
      issn:
         1472-6963
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health
      address:
         name:Department of Medicine, University of Colorado Denver School of Medicine, Denver, Colorado, USA. At the time of writing, Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill School of Medicine
      address:
         name:Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill
      address:
         name:Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill School of Medicine
      address:
         name:Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
         type:PostalAddress
      name:University of North Carolina at Chapel Hill School of Medicine
      address:
         name:Department of Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Benjamin Shillinglaw
      affiliation:
            name:Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health
            address:
               name:Department of Medicine, University of Colorado Denver School of Medicine, Denver, Colorado, USA. At the time of writing, Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Anthony J Viera
      affiliation:
            name:University of North Carolina at Chapel Hill School of Medicine
            address:
               name:Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Teresa Edwards
      affiliation:
            name:University of North Carolina at Chapel Hill
            address:
               name:Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Ross Simpson
      affiliation:
            name:University of North Carolina at Chapel Hill School of Medicine
            address:
               name:Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Stacey L Sheridan
      affiliation:
            name:University of North Carolina at Chapel Hill School of Medicine
            address:
               name:Department of Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medicine, University of Colorado Denver School of Medicine, Denver, Colorado, USA. At the time of writing, Dr. Shillinglaw was a student at the University of North Carolina at Chapel Hill School of Medicine and the Public Health Leadership Program of the Gillings School of Global Public Health, Chapel Hill, USA
      name:Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
      name:Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, USA
      name:Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA
      name:Department of Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA

External Links {🔗}(106)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.7s.

LINK . SPRINGER . COM {}